Global Endoscopic Submucosal Dissection Market Insights Forecasts to 2032
- The Endoscopic Submucosal Dissection Market Size was valued at USD 320.55 Million in 2022.
- The Market is Growing at a CAGR of 5.4% from 2022 to 2032.
- The worldwide Endoscopic submucosal Dissection Market Size is expected to reach USD 542.48 Million by 2032.
- Asia-Pacific is expected to grow significant during the forecast period.
Get more details on this report -
The Global Endoscopic Submucosal Dissection Market Size is expected to reach USD 542.48 Million By 2032, at a CAGR of 5.4% during the forecast period 2022 to 2032.
Endoscopic Submucosal Dissection (ESD) is a minimally invasive, advanced endoscopic technique used for the precise and en-bloc removal of early-stage gastrointestinal tumors or lesions. This procedure allows for the removal of larger, superficial lesions that would otherwise require invasive surgery. During ESD, a specialized endoscope is inserted through the mouth or anus to access the affected area, and a combination of electrosurgical devices and techniques are employed to dissect and lift the lesion from the submucosal layer. ESD offers several advantages, such as shorter hospital stays, reduced postoperative complications, and improved patient outcomes compared to conventional surgery. However, it requires skilled endoscopists due to its complexity, making it an important option in the management of early gastrointestinal neoplasms.
This research report categorizes the market for endoscopic submucosal dissection market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the endoscopic submucosal dissection market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the endoscopic submucosal dissection market.
Global Endoscopic Submucosal Dissection Market Report Coverage
|Market Size in 2022:||USD 320.55 Million|
|Forecast Period 2022-2032 CAGR:||5.4%|
|2032 Value Projection:||USD 542.48 Million|
|Historical Data for:||2019-2021|
|No. of Pages:||200|
|Tables, Charts & Figures:||120|
|Segments covered:||COVID-19 Impact Analysis, By Product , By Indication, By End-User, By Region|
|Companies Covered:||Olympus Corporation, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Sumitomo Bakelite Co. Ltd., Creo Medical PLC, MTW-Endoskopie W.Haag KG, Ovesco Endoscopy AG, KARL STORZ SE & Co. KG, CONMED Corporation, Micro-Tech Endoscopy, and Other key words|
|Pitfalls & Challenges:||COVID-19 Empact,Challenges, Future, Growth, & Analysis|
Get more details on this report -
The endoscopic submucosal dissection (ESD) market is driven by several key factors, the rising prevalence of gastrointestinal disorders and the increasing incidence of early-stage gastrointestinal tumors are significant drivers of market growth. ESD offers a less invasive alternative to traditional surgery, making it an attractive option for patients and contributing to the market's expansion. The advancements in endoscopic technologies and techniques have improved the success rate and safety of ESD procedures, further propelling market demand. Additionally, the growing awareness among healthcare professionals and patients about the benefits of ESD in terms of reduced hospital stays, faster recovery, and improved patient outcomes has bolstered market adoption. Furthermore, favorable reimbursement policies and increased healthcare expenditure in many regions have facilitated the accessibility of ESD procedures, positively impacting the market's growth trajectory. Overall, these drivers collectively contribute to the continuous expansion and evolution of the endoscopic submucosal dissection market.
The endoscopic submucosal dissection (ESD) market faces several constraints that impact its growth, the technical complexity and a steep learning curve associated with ESD procedures pose a significant challenge, limiting its widespread adoption. Skilled endoscopists are required to perform ESD effectively, and the lack of expertise in some regions can hinder market expansion. The high cost of ESD equipment and procedures can be a deterrent, especially in healthcare systems with budget constraints. Additionally, the risk of complications, such as bleeding and perforation during ESD, may lead to apprehension among both patients and healthcare providers. Overcoming these restraints will be essential for realizing the full potential of the endoscopic submucosal dissection market.
- In 2022, the stomach cancer segment accounted for around 62.7% market share
On the basis of the indication, the global endoscopic submucosal dissection market is segmented into stomach cancer, colan cancer, and esophageal cancer. The dominance of the stomach cancer segment in the endoscopic submucosal dissection (ESD) market can be attributed to several factors. Stomach cancer, also known as gastric cancer, is one of the most prevalent forms of cancer globally, with a high incidence rate in many regions, particularly in Asia-Pacific. The rising prevalence of gastric cancer has increased the demand for effective and minimally invasive treatment options, driving the adoption of ESD as a preferred choice for early-stage gastric cancer management. ESD offers numerous advantages for treating early gastric cancer. It enables en-bloc resection of tumors, ensuring complete removal in a single procedure, which is crucial for achieving better outcomes and reducing the risk of tumor recurrence. Moreover, ESD's minimally invasive nature allows for shorter hospital stays, faster recovery times, and lower postoperative complications compared to conventional surgical interventions, making it an attractive option for both patients and healthcare providers. Additionally, advancements in endoscopic technologies and the expertise of skilled endoscopists have further improved the success rate and safety of ESD procedures, bolstering confidence in its application for treating stomach cancer. Furthermore, favorable reimbursement policies and increased awareness among healthcare professionals about the benefits of ESD have positively influenced its adoption in the management of gastric cancer. The stomach cancer segment continues to dominate the ESD market, and its prominence is expected to grow as the incidence of gastric cancer persists. With ongoing research and technological advancements, ESD's role in the treatment of stomach cancer is likely to expand, further solidifying its position as a leading therapeutic modality in the fight against this prevalent form of cancer.
- In 2022, the hospitals segment dominated with more than 57.2% market share
Based on the end-user, the global endoscopic submucosal dissection market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The dominance of the hospitals segment in the endoscopic submucosal dissection (ESD) market can be attributed to several key factors. Hospitals are the primary healthcare facilities where most medical procedures, including ESD, are performed. As ESD is a specialized and technically complex procedure, it requires advanced infrastructure, specialized equipment, and skilled healthcare professionals. Hospitals typically have the necessary resources and expertise to offer ESD services, making them the primary choice for patients and physicians seeking this treatment option. Moreover, hospitals often serve as referral centers for complex medical cases, including gastrointestinal disorders and early-stage gastrointestinal tumors. This positions them at the forefront of diagnosing and treating conditions that are amenable to ESD. As a result, hospitals see a substantial patient inflow seeking ESD services, further solidifying their dominant position in the market. Additionally, hospitals benefit from their multidisciplinary approach to patient care. They have access to various specialists, such as gastroenterologists, oncologists, and surgeons, who collaborate to ensure comprehensive patient management, from diagnosis to treatment. This integrated approach allows for better patient outcomes and fosters confidence among both patients and physicians in choosing hospitals for ESD procedures. Furthermore, hospitals often have established relationships with medical equipment manufacturers and suppliers, enabling them to stay up-to-date with the latest advancements in endoscopic technologies and ensuring access to state-of-the-art ESD equipment. Overall, the hospitals segment dominates the ESD market due to its comprehensive infrastructure, skilled healthcare professionals, and ability to provide the necessary resources for successful ESD procedures, positioning them as the primary providers of this advanced endoscopic technique.
Regional Segment Analysis of the Endoscopic Submucosal Dissection Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America dominated the market with more than 37.4% revenue share in 2022.
Get more details on this report -
Based on region, North America dominates the endoscopic submucosal dissection (ESD) market and holds the largest market share for several reasons, the region boasts a robust healthcare infrastructure and advanced medical facilities, facilitating the widespread adoption of ESD procedures. Additionally, North America has a high prevalence of gastrointestinal disorders and early-stage gastrointestinal tumors, driving the demand for minimally invasive treatment options like ESD. Moreover, the region is at the forefront of technological advancements in endoscopy, leading to the development of sophisticated ESD equipment and techniques that enhance procedural success and patient outcomes. Furthermore, favorable reimbursement policies and increased healthcare spending in North America further bolster the accessibility and affordability of ESD procedures, attracting both patients and healthcare providers alike. These factors combined position North America as a significant player in the global endoscopic submucosal dissection market.
- In March 2021, The acquisition of Hitachi, Ltd.'s Diagnostic Imaging-related Business by FUJIFILM Holdings Corporation (Japan) facilitated the expansion of FUJIFILM Corporation's medical systems business. Through this acquisition, FUJIFILM strengthened its presence and capabilities in the medical imaging and diagnostics market, contributing to its growth in the healthcare sector.
- In January 2021, Quest Innovations B.V. (Netherlands) was purchased by Olympus Corporation (Japan). Olympus was able to expand its surgical endoscopy capabilities and incorporate Quest's advanced FIS capabilities into its full medical imaging platform as a result of the purchase.
The report offers the appropriate analysis of the key organizations/companies involved within the global endoscopic submucosal dissection market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Companies:
- Olympus Corporation
- Boston Scientific Corporation
- FUJIFILM Holdings Corporation
- Sumitomo Bakelite Co. Ltd.
- Creo Medical PLC
- MTW-Endoskopie W.Haag KG
- Ovesco Endoscopy AG
- KARL STORZ SE & Co. KG
- CONMED Corporation
- Micro-Tech Endoscopy
Key Target Audience
- Market Players
- Government Authorities
- Consulting and Research Firm
- Venture Capitalists
- Value-Added Resellers (VARs)
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global endoscopic submucosal dissection market based on the below-mentioned segments:
Endoscopic Submucosal Dissection Market, By Product
- Gastroscopes & Colonoscopes
- Injection Agents
- Tissue Retractors
Endoscopic Submucosal Dissection Market, By Indication
- Stomach Cancer
- Colan Cancer
- Esophageal Cancer
Endoscopic Submucosal Dissection Market, By End-User
- Specialty Clinics
- Ambulatory Surgical Centers
Endoscopic Submucosal Dissection Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?